The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Veldman, C. M.
Right arrow Articles by Hertl, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Veldman, C. M.
Right arrow Articles by Hertl, M.
The Journal of Immunology, 2004, 172: 3883-3892.
Copyright © 2004 by The American Association of Immunologists

T Cell Recognition of Desmoglein 3 Peptides in Patients with Pemphigus Vulgaris and Healthy Individuals1

Christian M. Veldman2,*, Kerstin L. Gebhard2,*, Wolfgang Uter{dagger}, Ralf Wassmuth{ddagger}, Joachim Grötzinger§, Erwin Schultz* and Michael Hertl3,*

Departments of * Dermatology, and {dagger} Medical Informatics, Biometry, and Epidemiology, University of Erlangen-Nürnberg, Erlangen, Germany; {ddagger} Institute for Transplantation Diagnostics and Cell Therapeutics, Düsseldorf University Medical Center, Düsseldorf, Germany; and § Institute of Biochemistry, University of Kiel, Kiel, Germany

Pemphigus vulgaris is a severe autoimmune disease caused by autoantibodies against the cutaneous adhesion molecule, desmoglein 3 (Dsg3). The aim of this study was to characterize the specificity of autoreactive Th cells, which presumably regulate Dsg3-specific autoantibody production. Ninety-seven Th1 and Th2 clones isolated from 16 pemphigus patients and 12 HLA-matched healthy donors recognized the Dsg3 peptides, DG3(78-94), DG3(96-112), DG3(189-205), DG3(205-221), and DG3(250-266). Peptide DG3(96-112), and to a lesser extent DG3(250-266), was recognized by the majority of T cells from patients and healthy donors in association with HLA-DRB1*0402 and DQB1*0503 which were prevalent in the pemphigus patients and Dsg3-responsive healthy donors. Analyzing the V{beta}-chain of the TCR of the DG3(96-112)-specific T cells showed no restricted TCR usage. Peptides DG3(342-358) and DG3(376-392) were exclusively recognized by T cell clones (n = 13) from patients while DG3(483-499) was only recognized by T cell clones (n = 3) from a healthy donor. All Dsg3 peptides contained conserved amino acids at relative positions 1, 4, and 6; amino acids with a positive charge at position 4 presumably represent anchor motifs for DRB1*0402. These findings demonstrate that T cell recognition of distinct Dsg3 peptides is restricted by distinct HLA class II molecules and is independent from the development of pemphigus vulgaris.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. A. Gebe, B. B. Yue, K. A. Unrath, B. A. Falk, and G. T. Nepom
Restricted Autoantigen Recognition Associated with Deletional and Adaptive Regulatory Mechanisms
J. Immunol., July 1, 2009; 183(1): 59 - 65.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Takahashi, M. Kuwana, and M. Amagai
A Single Helper T Cell Clone Is Sufficient to Commit Polyclonal Naive B Cells to Produce Pathogenic IgG in Experimental Pemphigus Vulgaris
J. Immunol., February 1, 2009; 182(3): 1740 - 1745.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Ota, M. Aoki-Ota, K. Tsunoda, T. Nishikawa, S. Koyasu, and M. Amagai
Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance
Int. Immunol., October 1, 2008; 20(10): 1351 - 1360.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Takahashi, M. Amagai, T. Nishikawa, Y. Fujii, Y. Kawakami, and M. Kuwana
Novel System Evaluating In Vivo Pathogenicity of Desmoglein 3-Reactive T Cell Clones Using Murine Pemphigus Vulgaris
J. Immunol., July 15, 2008; 181(2): 1526 - 1535.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M. R Hussein, F. M. N. Ali, and A.-E. M M Omar
Immunohistological analysis of immune cells in blistering skin lesions
J. Clin. Pathol., January 1, 2007; 60(1): 62 - 71.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. R. Stanley and M. Amagai
Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin Syndrome
N. Engl. J. Med., October 26, 2006; 355(17): 1800 - 1810.
[Full Text] [PDF]


Home page
J. Immunol.Home page
J. Yang, N. A. Danke, D. Berger, S. Reichstetter, H. Reijonen, C. Greenbaum, C. Pihoker, E. A. James, and W. W. Kwok
Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein-Reactive CD4+ T Cells in Human Subjects.
J. Immunol., March 1, 2006; 176(5): 2781 - 2789.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Veldman, A. Pahl, S. Beissert, W. Hansen, J. Buer, D. Dieckmann, G. Schuler, and M. Hertl
Inhibition of the transcription factor foxp3 converts desmoglein 3-specific type 1 regulatory T cells into th2-like cells.
J. Immunol., March 1, 2006; 176(5): 3215 - 3222.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Thoma-Uszynski, W. Uter, S. Schwietzke, G. Schuler, L. Borradori, and M. Hertl
Autoreactive T and B Cells from Bullous Pemphigoid (BP) Patients Recognize Epitopes Clustered in Distinct Regions of BP180 and BP230
J. Immunol., February 1, 2006; 176(3): 2015 - 2023.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Veldman, A. Hohne, D. Dieckmann, G. Schuler, and M. Hertl
Type I Regulatory T Cells Specific for Desmoglein 3 Are More Frequently Detected in Healthy Individuals than in Patients with Pemphigus Vulgaris
J. Immunol., May 15, 2004; 172(10): 6468 - 6475.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.